Have a personal or library account? Click to login
Formulation and evaluation of mefenamic acid sustained release matrix pellets Cover

Formulation and evaluation of mefenamic acid sustained release matrix pellets

Acta Pharmaceutica
Volume 63 (2013): Issue 1 (March 2013)
By: Mohamed Abbas Ibrahim  
Open Access
|Mar 2013

References

  1. 1. H. Bechgaard and G. H. Nielsen, Controlled-release multiple-units and single-unit doses. A literature review, Drug Dev. Ind. Pharm. 4 (1978) 53-67; DOI: 10.3109/03639047809055639.10.3109/03639047809055639
    Search in Google Scholar
  2. 2. K. A. Mehta, M. S. Kislalioglu, W. Phuapradit, A. W. Malick and N. H. Shah, Release performance of a poorly soluble drug from a novel, Eudragit®-based multi-unit erosion matrix, Int. J. Pharm. 213 (2001) 7-12; DOI: 10.1016/S0378-5173 (00)00594-9.
    Search in Google Scholar
  3. 3. P. W. Heng, 15th International Symposium on Microencapsulation, Parma (Italy), September 18-21, 2005.
    Search in Google Scholar
  4. 4. T. Schaefer, P. Holm and H. G. Kristensen, Melt granulation in a laboratory scale high shear mixer, Drug Dev. Ind. Pharm. 19 (1990) 1249-1277; DOI: 10.3109/03639049009115960.10.3109/03639049009115960
    Search in Google Scholar
  5. 5. O. L. Sprockel, M. Sen, P. Shivanand and W. Prapaitrakul, A melt extrusion process for manufacturing matrix drug delivery systems, Int. J. Pharm. 155 (1997) 191-199; DOI: 10.1016/S0378- -5173(97)00165-8.
    Search in Google Scholar
  6. 6. C. De Brabander, C. Vervaet and J. P. Remon, Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion, J. Control. Release 89 (2003) 235-247; DOI: 10.1016/ S0168-3659(03)00075-0.10.1016/S0168-3659(03)00075-0
    Search in Google Scholar
  7. 7. N. Follonier, E. Doelker and E. T. Cole, Evaluation of hot melt extrusion as a new technique for the development of polymer base pellets for sustained release capsules containing high loadings of freely soluble drugs, Drug Dev. Ind. Pharm. 20 (1994) 1323-1339; DOI: 10.3109/03639049409038373.10.3109/03639049409038373
    Search in Google Scholar
  8. 8. F. Siepmann, S. Muschert, M. P. Flament, P. Leterme, A. Gayot and J. Siepmann, Controlled drug release from Gelucire based matrix pellets: Experiment and theory, Int. J. Pharm. 317 (2006) 136-143; DOI: 10.1016/j.ijpharm.2006.03.006.10.1016/j.ijpharm.2006.03.006
    Search in Google Scholar
  9. 9. E. S. Ghali, G. H. Klinger and J. B. Schwartz, Thermal treatment of beads with wax for controlled release, Drug Dev. Ind. Pharm. 15 (1989) 1311-328; DOI: 10.3109/03639048909062747.10.3109/03639048909062747
    Search in Google Scholar
  10. 10. R. Chatlapalli and B. D. Rohera, Study of effect of excipient source variation on rheological behavior of diltiazem HCl-HPMC wet masses using a mixer torque rheometer, Int. J. Pharm. 238 (2002) 139-151; DOI: 10.1016/S0378-5173(02)00065-0.10.1016/S0378-5173(02)00065-0
    Search in Google Scholar
  11. 11. J. L. P. Soh, C. W. Liew and P. W. S. Heng, Torque rheological parameters to predict pellet quality in extrusion-spheronization, Int. J. Pharm. 315 (2006) 99-109; DOI: 10.1016/j.ijpharm.2006.02.023.10.1016/j.ijpharm.2006.02.023
    Search in Google Scholar
  12. 12. G. M. Mahrous, M. A. Ibarhim, M. El-Badry and F. K. Al-Anazi, Indomethacin sustained release pellets prepared by extrusion/spheronization, J. Drug Deliv. Sci. Technol. 20 (2010) 119-125.10.1016/S1773-2247(10)50016-9
    Search in Google Scholar
  13. 13. L. Fang, S. Numajiri, D. Kobayashi, H. Ueda, K. Nakayama, H. Miyamae and Y. Morimoto, Physicochemical and crystallographic characterization of mefenamic acid complexes with alkanolamines, J. Pharm. Sci. 93 (2004) 144-154; DOI: 10.1002/jps.10468.10.1002/jps.1046814648644
    Search in Google Scholar
  14. 14. D. Shinkuma, T. Hamaguchi, Y. Yamanaka and N. Mizuno, Correlation between dissolution rate and bioavailability of different commercial mefenamic acid capsules, Int. J. Pharm. 21 (1984) 187-200; DOI: org/10.1016/0378-5173(84)90093-0.10.1016/0378-5173(84)90093-0
    Search in Google Scholar
  15. 15. C. V.Winder, D. H. Kaump, A. J. Glazko and E. L.Holmes, Pharmacology of the Fenamates - ExperimentalObservations on Flufenamic, Mefenamic, and Meclofenamic Acids, in Supplement to Annals ofPhysical Medicine - Fenamates in Medicine, Symposium (Ed. P. H. Kendall), Bailliere, Tindall and Cassell, London 1966.10.1093/rheumatology/VIII.suppl_1.7
    Search in Google Scholar
  16. 16. J. E. F. Reynolds, Martindale: The Extra Pharmacopoeia, 31rd ed., The Pharmaceutical Press, London 1998, pp. 58-59.
    Search in Google Scholar
  17. 17. A. Avgerinos and S. Malamataris, Bioavailability of controlled release indomethacin microspheres and pellets, Int. J. Pharm. 63 (1990) 77-80; DOI: org/10.1016/0378-5173(90)90104-C.10.1016/0378-5173(90)90104-C
    Search in Google Scholar
  18. 18. J. S. Rowe and J. E. Carless, Comparison of the in vitro dissolution behaviour of various indomethacin formulations with their in vivo bioavailability, J. Pham. Pharma. 33 (1981) 561-464; DOI: 10.1111/j.2042-7158.1981.tb13866.x.10.1111/j.2042-7158.1981.tb13866.x
    Search in Google Scholar
  19. 19. S. Y. Khan and M. Akhter, Glyceride derivatives as potential prodrugs: synthesis, biological activity and kinetic studies of glyceride derivatives of mefenamic acid, Pharmazie 60 (2005) 110-114.
    Search in Google Scholar
  20. 20. F. Sevgi, B. Kaynarsoy, M. Ozyazici, Ç. Pekcetin and D. Özyurt, A comparative histological study of alginate beads as a promising controlled release delivery for mefenamic acid, Pharm. Dev. Technol. 13 (2008) 387-392; DOI: 10.1080/10837450802244876.10.1080/10837450802244876
    Search in Google Scholar
  21. 21. P. C. Chen, Y. J. Park, L. C. Chang, D. S. Kohane, R. R. Bartlett, R. Langer and V. C. Yang, Injectable microparticle-gel system for prolonged and localized lidocaine release. I. In vitro characterization, J. Biomed. Mater. Res. A. 70 (2004) 412-419; DOI: 10.1002/jbm.a.30086.10.1002/jbm.a.30086
    Search in Google Scholar
  22. 22. M. D. Parker, R. C. Rowe and N. G. Upjohn, Mixer torque rheometry: A method for quantifying the consistency of wet granulations, Pharm. Tech. Int. 2 (1990) 50-64.
    Search in Google Scholar
  23. 23. M. D. Parker, P. York and R. C. Rowe, Binder-substrate interactions in wet granulation. 1: The effect of binder characteristics, Int. J. Pharm. 64 (1990) 207-216.
    Search in Google Scholar
  24. 24. P. Luukkonen, T. Schæfer, L. Hellén, A. M. Juppo and J. Yliruusi, Rheological characterization of microcrystalline cellulose and silicified microcrystalline cellulose wet masses using a mixer torque rheometer, Int. J. Pharm. 188 (1999) 181-192; DOI: 10.1016/S0928-0987(00)00197-4.10.1016/S0928-0987(00)00197-4
    Search in Google Scholar
  25. 25. V. R. Sinha, A. Aggarwal, S. Srivastava and H. Goel, Influence of operational variables in multi- -particulate delayed release systems for colon-targeted drug delivery of celecoxib using extrusion spheronization, Asian J. Pharm. 4 (2010) 102-109; DOI: 10.4103/0973-8398.68460.10.4103/0973-8398.68460
    Search in Google Scholar
  26. 26. M. F. L. Law and P. B. Deasy, Use of canonical and other analyses for the optimization of an extrusion-spheronization process for indomethacin, Int. J. Pharm. 146 (1997) 1-9; DOI: 10.1016/ S0378-5173(96)04741-2.10.1016/S0378-5173(96)04741-2
    Search in Google Scholar
  27. 27. M. A. Ibrahim, G. M. Mahrous, M. El-Badry and F. K. Al-Anazi, Indomethacin-loaded pellets prepared by extrusion/spheronization: Effect of cosolvents, Farmacia 59 (2011) 483-499.
    Search in Google Scholar
  28. 28. F. Zhou, C. Vervaet and J. P. Remon, Matrix pellets based on the combination of waxes, starches and maltodextrins, Int. J. Pharm. 133 (1996) 155-160; DOI: 10.1016/0378-5173(95)04431-0.10.1016/0378-5173(95)04431-0
    Search in Google Scholar
  29. 29. C. M. Adeyeye and J. C. Price, Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies, Pharm. Res. 11 (1994) 575-579; DOI: 10.1023/A: 1018931002991.
    Search in Google Scholar
  30. 30. R. W. Korsmeyer and N. A. Peppas, Macromolecular and Modeling Aspects of Swelling-controlledSystems, in Controlled Release Delivery Systems (Eds. T. J. Roseman and S. Z. Mansdorf), Dekker, New York 1983, pp. 77 -101.
    Search in Google Scholar
  31. 31. R.W. Korsmeyer, R. Gurny, E. Docler, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83)90064-9.10.1016/0378-5173(83)90064-9
    Search in Google Scholar
  32. 32. P. L. Ritger and N. A. Peppas, A simple equation for description of solute release ii. Fickian and anomalous release from swellable devices, J. Control. Release, 5 (1987) 37-42; DOI: 10.1016/0168- -3659(87)90035-6.
    Search in Google Scholar
DOI: https://doi.org/10.2478/acph-2013-0009 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 85 - 98
Published on: Mar 12, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
mefenamic acid,
matrix pellets,
mixer torque rheometer,
sustained release
Related subjects:
Pharmacy,
Pharmacy, other

© 2013 Mohamed Abbas Ibrahim, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Previous articleVolume 63 (2013): Issue 1 (March 2013)Next article